Erasca Inc (ERAS)
2.18
+0.04
(+1.87%)
USD |
NASDAQ |
May 06, 13:44
Erasca Price to Book Value: 1.043 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.024 |
| May 02, 2024 | 1.028 |
| May 01, 2024 | 0.9998 |
| April 30, 2024 | 0.9615 |
| April 29, 2024 | 0.9759 |
| April 26, 2024 | 0.9041 |
| April 25, 2024 | 0.8993 |
| April 24, 2024 | 0.8993 |
| April 23, 2024 | 0.9233 |
| April 22, 2024 | 0.885 |
| April 19, 2024 | 0.8563 |
| April 18, 2024 | 0.8563 |
| April 17, 2024 | 0.8802 |
| April 16, 2024 | 0.9233 |
| April 15, 2024 | 0.9567 |
| April 12, 2024 | 1.009 |
| April 11, 2024 | 1.096 |
| April 10, 2024 | 1.062 |
| April 09, 2024 | 1.081 |
| April 08, 2024 | 1.072 |
| April 05, 2024 | 1.005 |
| April 04, 2024 | 0.9998 |
| April 03, 2024 | 1.038 |
| April 02, 2024 | 1.028 |
| April 01, 2024 | 1.033 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.9854 |
| March 27, 2024 | 0.9854 |
| March 26, 2024 | 0.9472 |
| March 25, 2024 | 0.9902 |
| March 22, 2024 | 1.028 |
| March 21, 2024 | 1.028 |
| March 20, 2024 | 1.004 |
| March 19, 2024 | 0.9805 |
| March 18, 2024 | 0.9805 |
| March 15, 2024 | 1.024 |
| March 14, 2024 | 0.9948 |
| March 13, 2024 | 1.062 |
| March 12, 2024 | 1.024 |
| March 11, 2024 | 1.071 |
| March 08, 2024 | 1.090 |
| March 07, 2024 | 1.028 |
| March 06, 2024 | 1.062 |
| March 05, 2024 | 1.086 |
| March 04, 2024 | 1.124 |
| March 01, 2024 | 1.220 |
| February 29, 2024 | 1.138 |
| February 28, 2024 | 1.124 |
| February 27, 2024 | 1.177 |
| February 26, 2024 | 1.148 |
| February 23, 2024 | 1.110 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7443
Minimum
Dec 01 2023
5.588
Maximum
Oct 05 2021
1.913
Average
1.440
Median
Jan 30 2023
Price to Book Value Benchmarks
| Exelixis Inc | 3.003 |
| Geron Corp | 6.467 |
| Verastem Inc | 5.227 |
| Karyopharm Therapeutics Inc | -- |
| Kura Oncology Inc | 3.158 |
Price to Book Value Related Metrics
| Price | 2.18 |
| Earnings Yield | -37.61% |
| Market Cap | 330.26M |